Early laboratory evaluations that screen potential drug candidates often rely on simplified environments. Testing molecules at room temperature or in simplified chemical environments may not fully capture how they behave inside the human body. A new study from Northwestern University found that adjusting temperature and intracellular calcium levels can fundamentally change, and sometimes completely reverse, how a drug interacts with its target protein.
The research, published in Nature Structural & Molecular Biology, demonstrates that proteins are dynamic, shape-shifting molecules. Their physical structures change in response to their immediate surroundings. Because therapeutics work by binding to these proteins, small environmental shifts can alter how a drug interacts with its target.
Impact of temperature and calcium on target proteins
Led by Wei Lü, PhD, and Juan Du, PhD, professors of molecular biosciences and pharmacology at Northwestern University, the team focused on TRPM4, a protein channel involved in heart rhythm regulation and immune responses. The researchers examined how small molecules interact with the channel under different testing conditions.
Under standard laboratory conditions at room temperature, the compound triphenylphosphine oxide (TPPO) appeared inactive. However, when researchers adjusted the environment to human body temperature (37 degrees Celsius) and introduced physiologically relevant calcium levels, the compound strongly activated the TRPM4 channel.
A second compound, Necrocide-1, produced the opposite result. Under low-calcium conditions, it activated the channel as expected. When calcium levels increased, however, the compound lost much of its activity. To understand these changes, the team used cryo-electron microscopy to visualize TRPM4 at near-atomic resolution. Their analysis showed that the channel contains a flexible drug-binding region that changes shape in response to temperature and calcium levels, influencing which compounds can bind successfully.
Operational changes for drug discovery workflows
For laboratory leaders overseeing screening and analytical pipelines, the findings highlight a potential limitation of traditional high-throughput screening assays. If a compound appears inactive under standard laboratory conditions but becomes active under physiological conditions, researchers may overlook promising candidates during early-stage evaluation.
Incorporating physiological testing conditions into early-stage assessments could help researchers identify drug behaviors that remain hidden in simplified laboratory environments. While adding environmental controls may increase workflow complexity, it can provide a more complete understanding of how candidate compounds behave under biologically relevant conditions.
Designing smarter environment-aware pharmacology assays
The Northwestern researchers describe their approach as "environment-aware pharmacology," a framework that considers how physiological conditions influence drug-target interactions. Rather than evaluating compounds only under standardized laboratory settings, the approach seeks to understand how drugs behave in the environments they are likely to encounter in living systems.
The researchers suggest that future therapeutics could potentially be designed to respond selectively to specific cellular environments, such as elevated calcium levels associated with certain disease states. Such approaches could help improve drug specificity by activating compounds only when particular biological conditions are present.
For laboratories involved in drug discovery, these findings may prompt consideration of whether screening platforms and analytical workflows can reliably maintain physiologically relevant conditions throughout testing. Expanding the use of physiological testing conditions alongside structural biology tools such as cryo-electron microscopy could provide additional insight into how drug targets respond to their cellular environments and help researchers make more informed decisions during early-stage drug development.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
